ANALYSIS OF MITOCHONDRIAL TRANSFER RNA MUTATIONS IN BREAST CANCER
Ding H.J.1, Zhao Y.P.2, Jiang Z.C.3, Zhou D.T.4, Zhu R.1* Han-Jie Ding and Ya-Ping Zhao contribute equally for this work
*Corresponding Author: Ph.D. Rui Zhu, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Binwen Road No. 548, Hangzhou, P.R. China. Phone/Fax: 0086-0571-86633133, E-mail: zhuruizjtcm@yeah.net
page: 15

RESULTS

Mutational Analysis of mt-tRNA Genes in Breast Cancer. The complete mt-tRNA genes of 80 tumor tissues and normal controls were analyzed by PCR-Sanger sequencing. The clinical and pathological data of these patients are listed in Table 1. Sanger sequencing suggested the presence of five mutations: tRNAVal G1606A, tRNAIle A4300G, tRNASer(UCN) T7505C, tRNAGlu A14693G and tRNAThr G15927A (Figure 1). Notably, the G1606A and A4300G mutations were in heteroplasmic forms, whereas the T7505C, A14693G and G15927A mutations were in homoplasmic forms. Interestingly, none of these occurred in control subjects. Moreover, the G1606A, A4300G and G15927A mutations were found in one patient with breast cancer (1.25%), while the T7505C and A14693G mutations were identified in two patients with breast cancer (2.5%), the molecular characterization of these mutations is listed in Table 2. Assessments of the Pathogenicity. The following criteria were used to evaluate the pathogenic roles of mttRNA mutations: (1) had a relative high level of CI (≥75%) [26], (2) found < 1% in control group, (3) had the ability to affect the tRNA functions, (4) affected the mitochondrial functions. As can be seen from Figure 1 and Table 2, one mutation (G1606A) was located at acceptor arm, two mutations (A4300G and G15927A) occurred at anticodon stem, one mutation (T7505C) in D-arm and one mutation (A14693G) in TΨC-loop. Four mutations (G1606A, A4300G, T7505C and G15927A) disrupted the highly conserved Watson-Crick base-pairings. Thus, it may be anticipated that these mutations will disrupt the tRNA stability level and function. We further analyzed mitochondrial functions in patients carrying these mt-tRNA mutations, as shown in Figure 2. We found that patients with putative pathogenic mt-tRNA mutations had much lower levels of mtDNA copy number and ATP, as compared with the controls (p=0.0138 and 0.0362, respectively) In addition, the classical pathogenicity scoring system [25] was then used to assess the scores of these mt-tRNA mutations. As a result, the total scores of tRNAVal G1606A, tRNAIle A4300G, tRNASer(UCN) T7505C, tRNAGlu A14693G and tRNAThr G15927A mutations were 13, 11, 13, 9 and 13 points, which belonged to “definitely pathogenic” and “possibly pathogenic” according to its standard (Table 3).



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006